PRAME and HLA Class I expression patterns make synovial sarcoma a suitable target for PRAME specific T-cell receptor gene therapy

Synovial sarcoma expresses multiple cancer testis antigens that could potentially be targeted by T-cell receptor (TCR) gene therapy. In this study we investigated whether PRAME-TCR-gene therapy could be an effective treatment for synovial sarcoma by investigating the potential of PRAME-specific T-ce...

Descripción completa

Detalles Bibliográficos
Autores principales: Luk, Sietse J, van der Steen, Dirk M, Hagedoorn, Renate S, Jordanova, Ekaterina S, Schilham, Marco W, Bovée, Judith VMG, Cleven, Arjen HG, Falkenburg, JH Frederik, Szuhai, Karoly, Heemskerk, Mirjam HM
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6279314/
https://www.ncbi.nlm.nih.gov/pubmed/30524904
http://dx.doi.org/10.1080/2162402X.2018.1507600

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6279314/
https://www.ncbi.nlm.nih.gov/pubmed/30524904
http://dx.doi.org/10.1080/2162402X.2018.1507600

Ejemplares similares